GLAUKOS Corp·4

Jul 21, 4:26 PM ET

Thurman Alex R. 4

4 · GLAUKOS Corp · Filed Jul 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Glaukos (GKOS) CFO Alex Thurman Exercises Options, Sells Shares

What Happened Alex R. Thurman, CFO of Glaukos Corp (GKOS), exercised stock options and immediately sold shares on July 16, 2026. The filing shows an exercise of 10,000 shares at $38.68 each for $386,800, and an open-market sale of 10,000 shares at $160.00 each for $1,600,000. The Form 4 also lists a derivative conversion/disposition of 10,000 shares at $0 — the filing does not detail this line, but such entries commonly reflect option conversion mechanics or share surrender for withholding.

Key Details

  • Transaction date: July 16, 2026.
  • Exercises: 10,000 shares exercised at $38.68 = $386,800 (coded M).
  • Sale: 10,000 shares sold at $160.00 = $1,600,000 (coded S).
  • Derivative entry: 10,000 shares disposed at $0 (coded M) — not explained in the filing.
  • Plan: Both the sales and option exercises were executed under a Rule 10b5-1 trading plan adopted Dec 15, 2025 (footnotes F2, F3).
  • Other holdings noted: filing references 5,230 restricted stock units unvested and 225 shares purchased via the company ESPP (F1).
  • Vesting detail for the options: vest over four years (25% after one year, then monthly over three years) (F4).
  • Filing date: Form 4 filed July 21, 2026 for transactions on July 16, 2026 — this appears to be filed one business day late (Form 4s are normally due within two business days).

Context This was a classic exercise-and-sell (cashless exercise/sale) pattern: options were exercised and shares were sold the same day under a pre-established 10b5-1 plan. Such sales are often routine and pre-planned; they are not direct proof of bullish or bearish views by the insider. The derivative/disposition at $0 on the form likely relates to the mechanics of converting or settling the option but isn’t explained in the filing.

Insider Transaction Report

Form 4
Period: 2026-07-16
Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-07-16$38.68/sh+10,000$386,80053,906 total
  • Sale

    Common Stock

    [F2][F1]
    2026-07-16$160.00/sh10,000$1,600,00043,906 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3][F4]
    2026-07-1610,00010,000 total
    Exercise: $38.68Exp: 2026-10-06Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
  • [F3]The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
  • [F4]These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Signature
Diana Scherer, Attorney-in-Fact|2026-07-21

Documents

1 file
  • 4
    form4-07212026_080747.xmlPrimary